Clinical Efficacy and Safety Comparison of Rivaroxaban and Dabigatran for Nonvalvular Atrial Fibrillation Patients Undergoing Percutaneous Left Atrial Appendage Closure Operation

• मुख्य लेखकों: Xiaoye Li (लेखक), Xiaochun Zhang (लेखक), Qinchun Jin (लेखक), Ying Xue (लेखक), Wenjing Lu (लेखक), Junbo Ge (लेखक), Daxin Zhou (लेखक), Qianzhou Lv (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2021-06-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Objective: Due to the clinical complexity of warfarin, novel oral anticoagulation (NOAC) has been a feasible and safe alternative anticoagulant approach during left atrial appendage closure (LAAC). This study was designed to compare the efficacy and safety of rivaroxaban and dabigatran for nonvalvul...